Drug discovery is an immensely complex endeavor, taking 15 years on average and costing 100,000,000s of dollars. However, with attrition of clinical candidates running at ~96%. There is a clear understanding within the field that a vast amount of work is needed to increase our efficiency in finding new drug molecules.
One means to do this is from the cheminformatics based analysis of legacy drugs, failed development compounds and pre-clinical compounds that never progressed. Such analyzes will help us to identify what types of compounds and what types of molecules have a greater probability of success for a given disease.
This work require a good understanding of biological and ADME process, physical properties of molecules, information extraction and statistical analysis methods.